Shanghai Bio-heart Biological Technology Co., Ltd.

SEHK:2185 Stock Report

Market Cap: HK$433.3m

Shanghai Bio-heart Biological Technology Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

SEHK:2185 Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
22 Mar 24SellHK$3,794,066OrbiMed Advisors LLCCompany1,548,600HK$2.45

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of 2185?
Owner TypeNumber of SharesOwnership Percentage
Institutions11,598,1924.76%
VC/PE Firms20,753,0258.53%
Employee Share Scheme27,962,08111.5%
Individual Insiders45,645,58418.8%
Private Companies54,343,51622.3%
General Public83,114,70234.1%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 9 shareholders own 65.86% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
18.8%
Li Wang
45,645,584HK$81.2m0%no data
11.5%
Shanghai Baixinantong Enterprise Management Consulting L.P
27,962,081HK$49.8m0%no data
10.4%
Shanghai Baihate Enterprise Management Consulting L.P.
25,402,420HK$45.2m0%no data
8.53%
TPG Asia VII SF Pte. Ltd
20,753,025HK$36.9m0%no data
6.87%
Tibet Zhenshan Venture Capital Investment L.P.
16,717,998HK$29.8m0%no data
5.02%
Magic Grace Ltd.
12,223,098HK$21.8m0%no data
4.67%
OrbiMed Advisors LLC
11,356,392HK$20.2m0%0.04%
0.057%
China Asset Management (Hong Kong) Limited
138,400HK$246.4k0%no data
0.042%
HuaAn Fund Management Company Ltd.
103,400HK$184.1k0%no data